Related references
Note: Only part of the references are listed.Subthreshold Change in Glycated Hemoglobin and Body Mass Index After the Initiation of Second-Generation Antipsychotics Among Patients With Schizophrenia or Bipolar Disorder: A Nationwide Prospective Cohort Study in Japan
Ryo Sawagashira et al.
JOURNAL OF CLINICAL PSYCHIATRY (2022)
Male-Specific Metabolic Considerations Concerning the Prescription of Second-Generation Antipsychotics to Adolescents
Timothy R. Rice et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2021)
Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances
Yoshifumi Inoue et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2021)
Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia
Diana Z. Paderina et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies
Miquel Bernardo et al.
ADVANCES IN THERAPY (2021)
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study
Tomihisa Niitsu et al.
ASIAN JOURNAL OF PSYCHIATRY (2020)
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study
Philip D. Harvey et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials
Taro Kishi et al.
PHARMACOPSYCHIATRY (2019)
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Tali Bretler et al.
BMC MEDICINE (2019)
Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
Young Sup Woo et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths
Wayne A. Ray et al.
JAMA PSYCHIATRY (2019)
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
Fiona J. Charlson et al.
SCHIZOPHRENIA BULLETIN (2018)
A widening longevity gap between people with schizophrenia and general population: A literature review and call for action
Ellen E. Lee et al.
SCHIZOPHRENIA RESEARCH (2018)
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial
Huafang Li et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
Weight gain and antipsychotics: a drug safety review
Richard Musil et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Pharmacokinetics and pharmacodinamics of psychotropic drugs: effect of sex
Donatella Marazziti et al.
CNS SPECTRUMS (2013)
Striatal and Extrastriatal Dopamine D2 Receptor Occupancy by a Novel Antipsychotic, Blonanserin A PET Study With [11C]Radopride and [11C]FLB 457 in Schizophrenia
Amane Tateno et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Efficacy and Tolerability of Blonanserin in the Patients With Schizophrenia: A Randomized, Double-blind, Risperidone-Compared Trial
Jaewon Yang et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms
Gavin P. Reynolds et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications
S. Gentile
OBESITY REVIEWS (2009)
A systematic review of longitudinal outcome studies of first-episode psychosis
N. M. Menezes et al.
PSYCHOLOGICAL MEDICINE (2006)
Hormonal correlates of clozapine-induced weight gain in psychotic children: An exploratory study
AL Sporn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2005)
Risk of Weight Gain Associated with Antipsychotic Treatment: Results From the Canadian National Outcomes Measurement Study in Schizophrenia
Roger S. McIntyre et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2003)
Share Paper
